GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » LumiraDx Ltd (OTCPK:LMDXF) » Definitions » Issuance of Debt

LumiraDx (LumiraDx) Issuance of Debt : $1.4 Mil (TTM As of Jun. 2023)


View and export this data going back to 2021. Start your Free Trial

What is LumiraDx Issuance of Debt?

LumiraDx's Issuance of Debt for the three months ended in Jun. 2023 was $0.1 Mil.

LumiraDx's Issuance of Debt for the trailing twelve months (TTM) ended in Jun. 2023 was $1.4 Mil.


LumiraDx Issuance of Debt Historical Data

The historical data trend for LumiraDx's Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LumiraDx Issuance of Debt Chart

LumiraDx Annual Data
Trend Dec19 Dec20 Dec21 Dec22
Issuance of Debt
127.70 133.31 361.83 54.63

LumiraDx Quarterly Data
Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Issuance of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.03 0.62 0.62 0.15

LumiraDx Issuance of Debt Calculation

Issuance of Debt represents all the cash inflow from debt, including both long-term debt and short-term debt.

Issuance of Debt for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


LumiraDx Issuance of Debt Related Terms

Thank you for viewing the detailed overview of LumiraDx's Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


LumiraDx (LumiraDx) Business Description

Traded in Other Exchanges
N/A
Address
C/o Ocorian Trust (Cayman) Ltd, Windward 3, P.O. Box 1350, Regatta Office Park, Grand Cayman, CYM, KY1-1108
LumiraDx Ltd is a next-generation point of care diagnostics company. It manufactures and commercializes an innovative diagnostic Platform that supports a broad menu of tests with lab comparable performance at the point of care. Geographical presence in United States, Italy, UK, Germany, Colombia, Sweden and Other countries. Majority revenue derives from U.S.